Market gets first new anti-stroke treatment in 50 years

Market gets first new anti-stroke treatment in 50 yearsAmong elderly people who have atrial fibrillation, in clinical trials, Pradaxa was found to cut the chance of a devastating brain attack by more than a third and was found better than the standard treatment warfarin.

It is even easier to take this new blood-thinning medication as no regular trips to doctor is needed to ensure that the right dose is being taken and no need to watch eating and drinking.

Among the 1.2million people in Britain who have atrial fibrillation, it is being hoped by manufacturers that money will be saved alongwith several lives with Pradaxa.

Before approving the pill for being used in the health service, more data on savings has been asked by Nice, England's drug rationing body.

GPs can start prescribing the pill from today as the European Medicines Agency has approved the drug.

Prof John Camm, head of the department of Cardiac and Vascular Sciences at St George's Hospital, London, said, "Often the first time someone finds out they have atrial fibrillation is when they have a stroke, which is a real disaster. A new anticoagulant, like Pradaxa, is going to be very important for eligible patients."